CareDx Inc (CDNA.OQ)
CDNA.OQ on NASDAQ Stock Exchange Global Market
12.49USD
19 Jul 2018
12.49USD
19 Jul 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$12.49
$12.49
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
190,927
190,927
52-wk High
$16.00
$16.00
52-wk Low
$1.15
$1.15
About
CareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $126.68 |
| Shares Outstanding(Mil.): | 22.54 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
BRIEF-Caredx Inc Enters Into A License And Commercialization Agreement With Illumina
* CAREDX INC - ON MAY 4, 2018, CO ENTERED INTO A LICENSE AND COMMERCIALIZATION AGREEMENT WITH ILLUMINA, INC - SEC FILING
BRIEF-Caredx Enters Into A Credit Agreement And Guaranty - SEC Filing
* CAREDX SAYS ON APRIL 17 ENTERED INTO A CREDIT AGREEMENT AND GUARANTY - SEC FILING
BRIEF-Caredx Launches Heartcare For Heart Transplant Recipients
* ANNOUNCED LAUNCH OF HEARTCARE, A COMPREHENSIVE REJECTION SURVEILLANCE SOLUTION FOR HEART TRANSPLANT RECIPIENTS Source text for Eikon: Further company coverage:
BRIEF-CareDx Q4 Non-Gaap Loss Per Share $0.09
* FY2018 REVENUE VIEW $61.5 MILLION -- THOMSON REUTERS I/B/E/S
BRIEF-Caredx - Entered Binding Commitment With Perceptive Advisors For Term Loan Of Between $15 Mln And $35 Mln
* CAREDX - ENTERED BINDING COMMITMENT WITH PERCEPTIVE ADVISORS FOR A TERM LOAN OF BETWEEN $15 MILLION AND $35 MILLION
Competitors
| Price | Chg | |
|---|---|---|
| Ardea Biosciences, Inc. (RDEA.OQ) | -- | -- |
| Nanosphere, Inc. (NSPH.OQ) | -- | -- |
Estimates